公司概覽
業務類別 Biotechnology
業務概覽 IRulya Therapeutics Inc is committed to transforming the lives of patients with serious, underserved diseases by developing disease-modifying therapies. The company is currently developing LAM-001 for the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD), bronchiolitis obliterans syndrome post-lung transplant (BOS), and sarcoidosis-associated pulmonary hypertension (SAPH). A Phase 2a study in PH patients has been completed; a Phase 2 clinical study in BOS patients is ongoing; a Phase 2b clinical study in PH-ILD is ongoing; and a Phase 2 clinical study in SAPH is ongoing.
公司地址 611 Gateway Boulevard, Suite 273, South San Francisco, CA, USA, 94080
電話號碼 +1 415 910-5717
傳真號碼 --
公司網頁 https://www.quincetx.com
員工數量 38
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Brigette Roberts, M.D. Chief Executive Officer, Director and Chief, Corporate Affairs -- 09/10/2026
Mr. John Militello, C.P.A. Chief Financial Officer -- 09/10/2026
Dr. Keith R. Fandrick, PhD Chief Operating Officer -- 09/10/2026
 
董事會成員
董事會 職務 更新日期
Dr. Brigette Roberts, M.D. Chief Executive Officer, Director and Chief, Corporate Affairs 09/10/2026
Ms. Leone D Patterson, M.B.A. Director 09/10/2026
Mr. Drayton Wise Director 09/10/2026
Dr. Catherine M. Bonuccelli, M.D. Director 09/10/2026
Mr. James Valentine Director 09/10/2026
 
所屬ETF (更新日期: 14/11/2026 02:22)
代號 名稱 佔比% ▼ 持有日期
GUGGuggenheim Active Allocation Fund0.00002%31/08/2026
BUSMEA Bridgeway Ultra-Small Company Mkt ETF<0.000001%31/03/2026
ITOTiShares Core S&P Total US Stock Mkt ETF<0.000001%06/03/2026
IWCiShares Micro-Cap ETF<0.000001%26/06/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.